John R Fischer

PE pumps capital into heart health: 5 deals

Antin, Arlington, Carlyle, GTCR and Webster Equity are among the PE firms pursuing investments in the heart health market.

Bain, Capza, Crestview keen on aviation services; Carousel Capital closes continuation fund for Ethos

A look at some recent investments by PE firms into the aviation sector; Carousel Capital closes a continuation fund for Ethos Risk Services.

Archimed, Astorg, HCAP target lab services; SK Capital to divest supply chain service assets

Demand for laboratory services has piqued the interest of PE investors, such as Archimed, Astorg and HCAP; SK Capital has inked an agreement to sell a trio of assets in the pharmaceutical supply chain sector to Siegfried Holding AG; who you might recommend for our upcoming Women in PE feature.

PE collects healthcare laboratory service assets: 5 deals

Archimed, Astorg, HCAP and Salt Creek Capital are among the PE firms investing in the medical laboratory sector.

Astorg, Charterhouse, Grant Avenue bet on dietary supplements; Vistria, EQT target secondaries market; Last chance for entries to PE Hub's Deal of the Year

Exploring trends and transactions in the dietary supplements space; parsing Vistria‘s debut multi-asset CV transaction and EQT’s entry into the secondaries market with its acquisition of Coller Capital; a reminder: today is the deadline for submissions to PE Hub’s Deal of the Year Awards.

PE goes for dietary supplements: 6 deals

Astorg, Charterhouse and Grant Avenue Capital are among the PE firms investing in the dietary supplements sector.

Medline shows 'the IPO window is open for scaled, high-quality assets'

'Being public gives the company a very attractive cost of capital currency to go and think creatively about what future deals Medline would like to do,' said Carlyle's Robert Schmidt about the largest IPO of 2025.

DFW Capital, GPP, SK Capital eye pharma commercialization; Chicago Bears QB Caleb Williams’ 888 Midas gears up for future investment plays

Rounding up five deals in the pharma commercialization segment, and delving into trends driving that activity; a discussion with 888 Midas’ Ross Walker on the firm’s strategy for investing in the sports, health tech sectors over the next few years; zeroing in on Water Street Healthcare Partners’ investment in a tech-enabled company focused on optimizing hospital pharmacy operations.

PE snaps up pharmaceutical commercialization assets: 5 deals

DFW, Great Point Partners, SK Capital and Water Street Healthcare Partners are among the PE firms investing in pharma commercialization services.

Exclusive: Sheridan buys ICANotes, the firm's first investment in EHR software

Sheridan expects to grow ICANotes through add-ons and possibly through a relationship with another portco, SimiTree.